ANALYSIS OF THE NUCLEOTIDE-SEQUENCE VARIATION OF THE ANTIGEN-BINDING DOMAIN OF DR-ALPHA AND DQ-ALPHA MOLECULES AS RELATED TO THE EVOLUTION OF PAPILLOMAVIRUS-INDUCED WARTS IN RABBITS
Rc. Han et al., ANALYSIS OF THE NUCLEOTIDE-SEQUENCE VARIATION OF THE ANTIGEN-BINDING DOMAIN OF DR-ALPHA AND DQ-ALPHA MOLECULES AS RELATED TO THE EVOLUTION OF PAPILLOMAVIRUS-INDUCED WARTS IN RABBITS, Journal of investigative dermatology, 103(3), 1994, pp. 376-380
We previously found that regression of skin warts induced by the Shope
cottontail rabbit papillomavirus in New Zealand White rabbits, as wel
l as malignant conversion of persistent warts, are linked to a restric
tion fragment length polymorphism of the major histocompatibility comp
lex class II DR alpha and DQ alpha genes. To find out whether this imm
unogenetic control could be connected with the antigen binding and pre
sentation function of the alpha 1 domain of class II molecules, we hav
e sequenced the exon 2 of the four DR alpha EcoRI and six of the seven
DQ alpha PvuII restriction fragment length polymorphism alleles ident
ified, and deduced the encoded amino acid sequences. We found no amino
acid polymorphism among DR alpha alleles, indicating that the alpha 1
domain of the DR alpha chain does not condition wart regression or ca
ncer development. In contrast, 27 of the 82 amino acids of the DQ alph
a 1 domain were found variable, defining five amino acid sequence alle
les. The restriction fragment length polymorphism allele linked to reg
ression and another allele not linked to regression share the same alp
ha 1 domain, indicating that wart regression is rather conditioned by
a closely linked gene. The most divergent DQ alpha 1 allele, however,
was that associated with a higher risk of cancer. Alignment of rabbit
and human DQ alpha exon 2 alleles disclosed that amino acid charge var
iations occur at positions assumed to be important for peptide binding
in humans. By modulating the affinity for tumor-specific antigenic pe
ptides, such transitions could affect immune surveillance and, thus, c
ondition the risk for progression to carcinoma of papillomavirus-assoc
iated lesions.